Skin infections have accelerated in the past decade, often caused by Staphylococcus aureus, the leading cause of skin and soft tissue infections (SSTI). In addition, strains of S. aureus are developing resistance to most conventional antibiotic treatment options. Antibiotic resistance is a growing epidemic and is estimated by the Centers for Disease Control and Prevention to cost $20 billion annually in excess health costs and $35 billion in other societal costs. Thus, it is evident that new strategies are needed to combat this growing public health threat.
展开▼
